NASDAQ:MESO

Mesoblast Stock Insider Trading

Healthcare > Biotechnology

Buy MESO

*Your capital is at risk

$15.50

+1.13 (+7.86%)

At Close: Jun 22, 2026

Mesoblast Stock Insider Power

Based on the 78 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 31.39M and sold 0 MESO shares in the last 78 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 78 transactions)	100.00
● Buy	31.39M shares
● Sell	0 shares
100% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 10, 2028 Buy	Options	George Gregory Director	Director	66 666 Value: $114.7K
Apr 10, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	2 324 072 Value: $3.44M
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	105 000 Value: $153.3K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	500 000 Value: $720.0K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	10 000 Value: $14.4K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	4 760 Value: $7K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	20 000 Value: $28.6K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	10 000 Value: $14.3K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	5 240 Value: $7K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	10 000 Value: $14.3K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	5 000 Value: $7K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	10 000 Value: $14.3K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	10 000 Value: $14.3K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	10 000 Value: $14.1K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	886 890 Value: $1.27M
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	500 000 Value: $7.20M
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	10 000 Value: $144.0K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	4 760 Value: $68.5K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	20 000 Value: $286.0K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	10 000 Value: $143.0K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	5 240 Value: $74.7K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	10 000 Value: $142.5K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	5 000 Value: $71.5K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	10 000 Value: $143.0K
Apr 09, 2026 Buy	Ordinary Shares P-Purchase	George Gregory	Director	10 000 Value: $143.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT MESOBLAST LTD

Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchyma...

Read Full Profile Here